VasoninВазонин
A historical name for a polypeptide preparation derived from blood-vessel walls. The available sources do not establish its precise composition or its relationship to Vasolin.
What the studies found
Animal research · 1986
[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].
Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.
Study notes · methods, sources and limitations
Participants or model Rabbits with diet-induced peroxidation syndrome
Important limitations
- This partial experimental effect does not establish vascular protection or a favorable bleeding-risk balance in humans. Full methods, reporting completeness and independent replication remain to be appraised.
Farmakologiia i toksikologiia · PMID 3817141 · Original journal report
Animal research · 1984
[Effect of vascular wall polypeptides on the hemostatic system].
Vasonin prolonged clotting time, altered platelet counts and delayed aggregation in a rat experiment.
Study notes · methods, sources and limitations
Participants or model Rats exposed to a bovine vascular-wall polypeptide fraction
Important limitations
- Human thrombosis prevention, clinical bleeding risk and formulation equivalence remain unestablished. Full methods, reporting completeness and independent replication remain to be appraised.
Farmakologiia i toksikologiia · PMID 6714401 · Original journal report
About Vasonin
Research background
Historical reports refer to a vascular-wall polypeptide preparation as Vasonin. They do not specify whether its manufacturing process matched that of Vasolin.
- Compound class
- Archival preparation lead
- Research collection
- Peptide bioregulation · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
The published studies use animal or cell models.
Study methods
Study records describe the tested models, comparators and reported outcomes.
Independent replication
New citations are not automatically independent replication; shared programs and translated reports require cohort checks
Source access
New indexed primary abstracts and/or report reproductions linked; review depth shown per source
Safety evidence
Reported tolerability is not proof of safety; uncommon harms and long-term outcomes remain unresolved
Open a topic for the evidence assessment.
Findings by study
Animal research · 1986
[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].
Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.
Study notes and original source
[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].
· Original journal report
Kuzik BI, Mishchenko VP, Khavinson VKh, Morozov VG, Gritsaĭ NN · Farmakologiia i toksikologiia · PMID 3817141
Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.
- Population / setting
- Rabbits with diet-induced peroxidation syndrome
- Source reviewed
- Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Study limitations
- This partial experimental effect does not establish vascular protection or a favorable bleeding-risk balance in humans.
- Full methods, reporting completeness and independent replication remain to be appraised.
Reviewed 2026-10-05.
Animal research · 1984
[Effect of vascular wall polypeptides on the hemostatic system].
Vasonin prolonged clotting time, altered platelet counts and delayed aggregation in a rat experiment.
Study notes and original source
[Effect of vascular wall polypeptides on the hemostatic system].
· Original journal report
Kuznik BI, Khavinson VKh, Morozov VG, Arushanian LG, Tsybikov NN · Farmakologiia i toksikologiia · PMID 6714401
Vasonin prolonged clotting time, altered platelet counts and delayed aggregation in a rat experiment.
- Population / setting
- Rats exposed to a bovine vascular-wall polypeptide fraction
- Source reviewed
- Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Study limitations
- Human thrombosis prevention, clinical bleeding risk and formulation equivalence remain unestablished.
- Full methods, reporting completeness and independent replication remain to be appraised.
Reviewed 2026-10-05.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗